Machine Learning of Human Pluripotent Stem Cell-Derived Engineered Cardiac Tissue Contractility for Automated Drug Classification
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Accurately predicting cardioactive effects of new molecular entities for therapeutics remains a daunting challenge. Immense research effort has been focused toward creating new screening platforms that utilize human pluripotent stem cell (hPSC)-derived cardiomyocytes and three-dimensional engineered cardiac tissue constructs to better recapitulate human heart function and drug responses. As these new platforms become increasingly sophisticated and high throughput, the drug screens result in larger multidimensional datasets. Improved automated analysis methods must therefore be developed in parallel to fully comprehend the cellular response across a multidimensional parameter space. Here, we describe the use of machine learning to comprehensively analyze 17 functional parameters derived from force readouts of hPSC-derived ventricular cardiac tissue strips (hvCTS) electrically paced at a range of frequencies and exposed to a library of compounds. A generated metric is effective for then determining the cardioactivity of a given drug. Furthermore, we demonstrate a classification model that can automatically predict the mechanistic action of an unknown cardioactive drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solving Multiclass Learning Problems via Error-Correcting Output Codes
Dietterich, T. G., & Bakiri, G. (1995) · Journal of Artificial Intelligence Research · doi:10.1613/jair.105 · Cited by 2,739
Engineering Adolescence: Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes
Yang, X., Pabon, L., & Murry, C. E. (2014) · Circulation Research · doi:10.1161/circresaha.114.300558 · Cited by 939 · cited 2×
“…of breceptors (Steinberg, 1999) 10 8 to 10 4 10 Norepinephrine adrenergic agonist mixed adrenergic agonist that stimulates both a and breceptors (Yang et al., 2014) 10 9 to 10 5 8 Digoxin cardiac glycoside a cardiac glycoside that inhibits Na+/K+-ATPase, resulting in higher intracellular Na+;…”
BackgroundStructural and Functional Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells
Lundy, S. D., Zhu, W.-Z., Regnier, M., & Laflamme, M. A. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0490 · Cited by 738 · cited 1×
“Studies have shown that hPSC-CMs elicit a minimal to non-existent response to certain positive inotropic compounds, such as b-adrenergic agonists, because of immature intracellular structures (Lundy et al., 2013; Pillekamp et al., 2012).”
BackgroundAdvancing functional engineered cardiac tissues toward a preclinical model of human myocardium
Turnbull, I. C., Karakikes, I., Serrao, G. W., Backeris, P., Lee, J., Xie, C., Senyei, G., Gordon, R. E., Li, R. A., Akar, F. G., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-228007 · Cited by 184 · cited 6×
“9 mg/mL), and human foreskin fibroblasts (100,000 cells per strip) as previously described (Turnbull et al., 2014).”
BackgroundMethodInfluentialSelf-citationWeng, Z., Kong, C.-W., Ren, L., Karakikes, I., Geng, L., He, J., Chow, M. Z. Y., Mok, C. F., Chan, H. Y. S., Webb, S. E., et al. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0509 · Cited by 109 · cited 1×
“hvCTS Formation Human ventricular cardiomyocytes were differentiated from an hES2 stem cell line with a Wnt inhibitor-based protocol as described previously (Weng et al., 2014).”
MethodSelf-citationLiu, J., Lieu, D. K., Siu, C. W., Fu, J.-D., Tse, H.-F., & Li, R. A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00060.2009 · Cited by 109 · cited 1×
“…and co-cultured with fibroblasts, they can be further matured through additional techniques, such as conditioning by electrical stimulation, a cellular tri-culture including endothelial cells, or forced expression of selected proteins (Eng et al., 2016; Liu et al., 2009; Ravenscroft et al., 2016).”
BackgroundSelf-citationEngineered cardiac organoid chambers: toward a functional biological model ventricle
Lee, E. J., Kim, D. E., Azeloglu, E. U., & Costa, K. D. (2008) · Tissue Engineering Part A · doi:10.1089/tea.2007.0351 · Cited by 84 · cited 2×
“…platforms employ hPSC-CMs in a two-dimensional manner (e.g., monolayer), while others attempt to recapitulate aspects of the three-dimensional environment of native myocardium bymodeling the cells as cardiacmuscle fibers or heart chambers (Chen et al., 2014; Huebsch et al., 2016; Lee et al., 2008).”
BackgroundMethodSelf-citation
Cited by
Organs-on-a-chip: a union of tissue engineering and microfabrication
Zhao, Y., Wang, E. Y., Lai, F. B. L., Cheung, K., & Radisic, M. (2023) · Trends in Biotechnology · doi:10.1016/j.tibtech.2022.12.018 · Cited by 93
Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures
Sacchetto, C., Vitiello, L., de Windt, L. J., Rampazzo, A., & Calore, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093404 · Cited by 91
Engineering the cardiac tissue microenvironment
Ronan, G., Bahcecioglu, G., Aliyev, N., & Zorlutuna, P. (2024) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ad0ea7 · Cited by 4
Metadata
- Authors
- Lee, E. K., Tran, D. D., Keung, W., Chan, P., Wong, G., Chan, C. W., Costa, K. D., Li, R. A., & Khine, M.
- Venue
- Stem Cell Reports
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 9
- Issue
- 5
- Pages
- 1560-1572
- ISSN
- 2213-6711 (ISSN-L)
- OpenAlex
- W2761436661
- Cited by
- 63
- References
- 7
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Machine Learning of Human Pluripotent Stem Cell-Derived Engineered Cardiac Tissue Contractility for Automated Drug Classification. https://app.cochat.ai/papers/10.1016/j.stemcr.2017.09.008
- The paper
- Lee, E. K., Tran, D. D., Keung, W., Chan, P., Wong, G., Chan, C. W., Costa, K. D., Li, R. A., & Khine, M. (2017). Machine Learning of Human Pluripotent Stem Cell-Derived Engineered Cardiac Tissue Contractility for Automated Drug Classification. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2017.09.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.